Skip to content

A study to assess treatment in patient who diagnosed with alcohol withdrawal syndrome

A Retrospective, Non-Interventional, Multi-Center Study to Assess Treatment Pattern in Alcohol Withdrawal Syndrome Patients during Hospitalization and Post Discharge Compliance

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038427
Enrollment
1000
Registered
2021-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F102- Alcohol dependence

Interventions

None listed

Sponsors

Abbott Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male/female of >= 18 years of age at the time of data collection. 2.Patient admitted with AWS Symptoms 3.Patient with at least 3 months documented follow ups

Exclusion criteria

Exclusion criteria: 1.Patient was directly admitted to the ICU when alcohol withdrawal treatment was initiated. 2.Patient who had a positive urine toxicology screen for BZDs (unless given for the treatment of alcohol withdrawal), barbiturates, opiates (unless administered at URMC prior to sampling), or other illegal substances.

Design outcomes

Primary

MeasureTime frame
To assess the treatment pattern of alcohol withdrawal patients during hospitalization, at discharge and follow upTimepoint: During hospitalisation and follow up (after discharge)

Secondary

MeasureTime frame
To assess clinical and demographic profiles of patients with alcohol withdrawal syndromeTimepoint: Age, Gender, Height and weight, BMI, Occupation, Medical history, Family history of alcohol dependence/other psychiatric illness, Adequate history of type of alcohol Co-relate the choice of BZDs with LFT levels (ALT/AST/Bilirubin ) as available Adjunctive treatment used for Alcohol deaddiction Average duration of hospital stay Nonpharmacological treatment used during the treatment

Countries

India

Contacts

Public ContactDr Shivani Acharya

Abbott Healthcare Private Limited

jejoe.karankumar@abbott.com7045011810

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026